Robert Prior
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 A.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 26, 2024
Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders.
Journal: Expert opinion on therapeutic targets
Published: September 21, 2024
PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.
Journal: Brain : a journal of neurology
Published: December 06, 2023
Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.
Journal: Experimental & molecular medicine
Published: November 10, 2023
HDAC3 Inhibition Stimulates Myelination in a CMT1A Mouse Model.
Journal: Molecular neurobiology
Published: August 27, 2021
CMT2Q-causing mutation in the Dhtkd1 gene lead to sensory defects, mitochondrial accumulation and altered metabolism in a knock-in mouse model.
Journal: Acta neuropathologica communications
Published: January 17, 2020
HDAC6 as a potential therapeutic target for peripheral nerve disorders.
Journal: Expert opinion on therapeutic targets
Published: October 27, 2018
Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.
Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.
Journal: Frontiers in neuroscience
Published: September 01, 2017
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
Journal: Brain : a journal of neurology
Published: June 13, 2017
Defective axonal transport: A common pathological mechanism in inherited and acquired peripheral neuropathies.
Journal: Neurobiology of disease
Published: December 07, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026